References
- 1. Ogden CL, Caroll MD, Curtin LR, et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. JAMA 2006; 295:1549-55.10.1001/jama.295.13.154916595758
- 2. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001;59:1498-509.10.1046/j.1523-1755.2001.0590041498.x11260414
- 3. daSilva AA, doCarmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep 2009;11:206-11.10.1007/s11906-009-0036-3281432919442330
- 4. Zoccali C, Mallamaci F. Obesity, diabetes, adiponectin and the kidney: a podocyte affair. Nephrol Dial Transplant 2008; 23:3767-3770.10.1093/ndt/gfn51718802210
- 5. Gotoh K, Inoue M, Masaki T, et al. Obesity-related chronic kidney disease is associated with spleen-derived IL-10. Nephrol Dial Transplant. 2013; 28:1120-130.10.1093/ndt/gfs44023229922
- 6. Jang SY, Kim IH, Ju EY, et al. Chronic kidney disease and metabolic syndrome in a general Korean population: the Third Korea National Health and Nutrition Examination Survey (KNHANES III) Study. J Public Health 2010;32:538-46.10.1093/pubmed/fdp12720061374
- 7. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:550-62.10.2215/CJN.0407120617699463
- 8. Shankar A, Leng C, Chial KS, et al. Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant 2008;23:1910-18.10.1093/ndt/gfm87818156460
- 9. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-50.10.1001/jama.291.7.84414970063
- 10. Grieve E, Fenwick E, Yang HC, Lean M. The disproportionate economic burden associated with severe and complicated obesity: a systematic review. Obes Rev 2013;14:883-97.10.1111/obr.1205923859626
- 11. Braun L, Sood V, Hogue S, et al. High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis 2012;5:151-63.
- 12. Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005;46:871-80.10.1053/j.ajkd.2005.08.01516253727
- 13. Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1695-702.10.1681/ASN.200506063816641153
- 14. Burton JO, Gray LJ, Webb DR, et al. Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Transplant. 2012;27:1860-66.10.1093/ndt/gfr57421965589
- 15. Nomura I, Kato J, Kitamura K. Association between body mass index and chronic kidney disease: A population-based, cross-sectional study of a Japanese community. Vasc Health Risk Manag 2009;5:315-20.
- 16. Ishizaka N, Ishizaka Y, Toda EI, Koike K, Seki G, Nagai R, Yamakado M. Association between obesity and chronic kidney disease in Japanese: differences in gender and hypertensive status? Hypertens Res 2007;30:1059-64.
- 17. Wang Y, Chen X, Song Y, et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008;73:19-33.10.1038/sj.ki.500258617928825
- 18. Komura H, Nomura I, Kitamura K, et al. Gender difference in relationship between body mass index and development of chronic kidney disease. BMC Res Notes 2013;6:463.10.1186/1756-0500-6-463383363824225117
- 19. Brown RN, Mohsen A, Green D, et al. Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant 2012;27:2776-80.10.1093/ndt/gfr75722442391
- 20. Munkhaugen J, Lydersen S, Wideroe TE, Hallan S. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am J Kidney Dis 2009;54:638-46.10.1053/j.ajkd.2009.03.02319515474
- 21. Gomez P, Ruilope LM, Barrios V, et al. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH Study. J Am Soc Nephrol 2006;17(12Suppl3):S194-S200.10.1681/ASN.200608091417130261
- 22. Popruk S, Tungtrongchitr R, Pongpaew P, et al. Relationship between soluble leptin receptor, leptin, lipid profiles and anthropometric parameters in overweight and obese Thai subjects. J Med Assoc Thai 2005;88:220-27.
- 23. Ogawa T, Hirose H, Yamamoto Y, et al. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism 2004;53:879-85.10.1016/j.metabol.2004.02.00915254881
- 24. Zhang Y, Ma AQ, Gong M, et al. Red blood cell level is increased in obese but not in non-obese patients with coronary heart disease. J Geriatr Cardiol 2010;7:143-46.
- 25. Qin Y, Melse-Boonstra A, Pan X, et al. Anemia in relation to body mass index and waist circumference among chinese women. Nutrition Journal 2013;12:1-3.10.1186/1475-2891-12-10354873223311667
- 26. Wärnberg J, Nova E, Moreno LA, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study 1,2,3. Am J Clin Nutr 2006;84:505-12.10.1093/ajcn/84.3.50516960163
- 27. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.10.1053/ajkd.2003.5000712500213
- 28. Haroun M, Jaar BG, Hoffman SC, et al. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003;14:2934-41.10.1097/01.ASN.0000095249.99803.85
- 29. Weycker D, Nichols GA, O Keeffe-Rosetti M, et al. Risk of chronic kidney disease in hypertensive patients with other metabolic conditions. Journal of Human Hypertension 2008;22:132-34.10.1038/sj.jhh.100227617728802
- 30. Yano Y, Fujimoto S, Sato Y, et al. Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int 2012;81:293-99.10.1038/ki.2011.34621956189
- 31. Cuppari L. Diagnosis of obesity in chronic kidney disease: BMI or body fat? Nephrol Dial Transplant 2013;28:119–21.
- 32. Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 2008; 52:29-38.10.1053/j.ajkd.2008.02.363405275718511168
- 33. Vupputuri S, Fox CS, Coresh J, et al. Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis 2009;53:993-1001.10.1053/j.ajkd.2008.12.043302843619394726
- 34. Silva MIB, Vale BS, Lemos CCS, Torres MRSG, Bregman R. Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients. Obesity 2013;21:546-52.10.1002/oby.2026123592662
- 35. Aggarwal N, Porter AC, Tang IYST, Becker BN, Akkina SK. Creatinine-based estimations of kidney function are unreliable in obese kidney donors. J Transplant 2012;1-5.10.1155/2012/872894327045822315657